Pricing

Log inSign up

Abivax

51 people · 0 jobs
‌

Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.

Industries

Biotechnology

Headquarters

Paris, France

Employees

11-50

Links

Org chart

Marc De Garidel
Chief Executive Officer
Collapse
Ida Hatoum
Chief People Officer
Didier Scherrer
Chief Scientific Officer
Didier Blondel
EVP, CFO & Board Secretary
Pierre Courteille
Chief Commercial Officer & VP of Business Development
Nadege Briancon-Eris
Senior Vice President, Program Management
Fabio Cataldi
EVP And Chief Medical Officer
David Zhang
Chief Strategy Officer

Board & advisors

PP
Philippe Pouletty
Chairman
Ian McGowan
Chairman of the Scientific Advisory Board
Carol Brosgart
Director
KH
Kinam Hong
Director
JB
Jean-Jacques Bertrand
Director
AL
Antonino Ligresti
Director
Corinna Zur Bonsen-Thomas
Member Board Of Directors, Interim Chairman 08/2022 - 05/2023,
Troy Ignelzi
Director
June Lee
Director
Christian Bréchot
Scientific Advisor
Christoph Huber
Scientific Advisor
Jürgen Rockstroh
Scientific Advisor
Lawrence R. Stanberry
Scientific Advisor
CT
Christian Trépo
Scientific Advisor
LT
Luc Teyton
Scientific Advisor

Similar companies

Sanofi

327 followers

Tango Therapeutics

3 followers

Valneva

3 followers

Pierre Fabre

18 followers

Cellares

5 followers

Gilead Sciences

173 followers

Regeneron

144 followers

Illumina

82 followers

Agilent Technologies

89 followers

Lonza

77 followers

Verily Life Sciences

48 followers

Explore companies